Genomic analysis unlocks the potential of denosumab as a targeted therapy for Crohn's disease.

Pranata R, Ratnasari N, Bayupurnama P, Indrarti F, Aulia N, Rahmawati H, Adikusuma W, Mugiyanto E, Irham LM, Gunarto C, Alya SS, Hadi VF, Sentosa GC, Wahyuningsih AT, Lin CF, Satria RD

Open source

DOI: 10.1038/s41598-025-28395-7
Published: 2025 Dec 29
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-025-28395-7,
  title = {Genomic analysis unlocks the potential of denosumab as a targeted therapy for Crohn's disease.},
  author = {Pranata R and Ratnasari N and Bayupurnama P and Indrarti F and Aulia N and Rahmawati H and Adikusuma W and Mugiyanto E and Irham LM and Gunarto C and Alya SS and Hadi VF and Sentosa GC and Wahyuningsih AT and Lin CF and Satria RD},
  year = {2025},
  journal = {Scientific reports},
  doi = {10.1038/s41598-025-28395-7},
  url = {https://doi.org/10.1038/s41598-025-28395-7}
}

RIS

TY  - JOUR
TI  - Genomic analysis unlocks the potential of denosumab as a targeted therapy for Crohn's disease.
AU  - Pranata R
AU  - Ratnasari N
AU  - Bayupurnama P
AU  - Indrarti F
AU  - Aulia N
AU  - Rahmawati H
AU  - Adikusuma W
AU  - Mugiyanto E
AU  - Irham LM
AU  - Gunarto C
AU  - Alya SS
AU  - Hadi VF
AU  - Sentosa GC
AU  - Wahyuningsih AT
AU  - Lin CF
AU  - Satria RD
PY  - 2025
JO  - Scientific reports
DO  - 10.1038/s41598-025-28395-7
UR  - https://doi.org/10.1038/s41598-025-28395-7
ER  -

APA

R, P., N, R., P, B., F, I., N, A., H, R., W, A., E, M., LM, I., C, G., SS, A., VF, H., GC, S., AT, W., CF, L., & RD, S. (2025). Genomic analysis unlocks the potential of denosumab as a targeted therapy for Crohn's disease.. Scientific reports. https://doi.org/10.1038/s41598-025-28395-7

Source records

pubmed · retrieved 2026-09-26T12:11:35.040Z
europe-pmc · retrieved 2026-09-26T12:11:35.043Z
doaj · retrieved 2026-09-26T12:11:35.018Z